Castle Biosciences Inc financial data

Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
Location
505 S Friendswood Drive, Suite 401, Friendswood, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 800 % +6.07%
Quick Ratio 18.4 % +11.7%
Debt-to-equity 15.6 % +19.6%
Return On Equity 4.24 %
Return On Assets 3.66 %
Operating Margin 2.61 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.5M shares +3.29%
Common Stock, Shares, Outstanding 28.5M shares +3.91%
Entity Public Float 587M USD +88.7%
Weighted Average Number of Shares Outstanding, Basic 27.8M shares +3.63%
Weighted Average Number of Shares Outstanding, Diluted 29.3M shares +9.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 332M USD +51.1%
Cost of Revenue 60.2M USD +33.8%
Research and Development Expense 52M USD -2.94%
Operating Income (Loss) 8.67M USD
Income Tax Expense (Benefit) 3.32M USD +3186%
Net Income (Loss) Attributable to Parent 18.2M USD
Earnings Per Share, Basic 0.66 USD/shares
Earnings Per Share, Diluted 0.62 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 120M USD +21.1%
Marketable Securities, Current 173M USD +20.2%
Accounts Receivable, after Allowance for Credit Loss, Current 51.2M USD +33.7%
Inventory, Net 8.14M USD +2.43%
Assets, Current 360M USD +21.8%
Property, Plant and Equipment, Net 22.3M USD +70.6%
Operating Lease, Right-of-Use Asset 11.6M USD -5.87%
Goodwill 10.7M USD 0%
Other Assets, Noncurrent 1.23M USD -14.7%
Assets 531M USD +17.2%
Accounts Payable, Current 6.9M USD -32.8%
Employee-related Liabilities, Current 32.6M USD +12.5%
Liabilities, Current 49.4M USD +3.62%
Deferred Income Tax Liabilities, Net 1.61M USD +680%
Operating Lease, Liability, Noncurrent 14.3M USD +1.21%
Other Liabilities, Noncurrent 16K USD -70.9%
Liabilities 75.4M USD +21.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 230K USD +69.1%
Retained Earnings (Accumulated Deficit) -200M USD +8.36%
Stockholders' Equity Attributable to Parent 456M USD +16.5%
Liabilities and Equity 531M USD +17.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.84M USD +73.1%
Net Cash Provided by (Used in) Financing Activities 10.6M USD +1362%
Net Cash Provided by (Used in) Investing Activities -19.7M USD -219%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 28.5M shares +3.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.9M USD -95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120M USD +21.1%
Deferred Tax Assets, Valuation Allowance 50.5M USD -8.16%
Deferred Tax Assets, Gross 73.2M USD -7.9%
Operating Lease, Liability 16M USD +4.57%
Depreciation 4.89M USD +47.5%
Payments to Acquire Property, Plant, and Equipment 9.15M USD +174%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 18.3M USD
Lessee, Operating Lease, Liability, to be Paid 22.8M USD -6.39%
Operating Lease, Liability, Current 1.67M USD +46.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.4M USD +6.58%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.95M USD +26.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.75M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.44M USD +9.26%
Deferred Tax Assets, Operating Loss Carryforwards 31.8M USD -32.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.49M USD +1.51%
Additional Paid in Capital 656M USD +7.59%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 11.1M USD +23.2%
Depreciation, Depletion and Amortization 3.34M USD +15.5%
Deferred Tax Assets, Net of Valuation Allowance 22.7M USD -7.32%
Share-based Payment Arrangement, Expense 50.3M USD -1.76%
Interest Expense 424K USD +3162%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%